PsA is no more the „little sister” of RA

Psoriasis Arthritis (PsA) as an inflammatory disease has many faces and presents interdisciplinary challenges to researchers. The last few years have seen marked increase in new therapies but there is still an unmet need in effective and well-toilerated treatments. PsA is no more the „little sister” of rheumatoid arthritis (RA); today, the disease may offer even more research options than RA.  The PARTNER Fellowship Program  enabled academic and patient orientated science to meet the huge need of patient orientated research in PsA.

Rik Lories, MD, PhD. Professor and Tissue Homeostatis and Disease Leader, Skeletal Biology and Engineering Research Center, University of Leuven, Belgium